Endocyte Back On Track To File Lead Candidate For EU Conditional Approval This Year

The U.S. biotech, which went public last year, will file EC145 and a companion diagnostic for conditional approval in Europe in platinum-resistant ovarian cancer based on findings from four Phase I and Phase II trials in the third quarter.